Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Nicke

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Lancet. Oncology|November 4, 2004
RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy?Charles Swanton, Barbara Nicke, Julian Downward
Handbook of Experimental Pharmacology|September 3, 2015
Functional Genomics in Pharmaceutical Drug DiscoveryRobert Adams, Michael Steckel, Barbara Nicke
Plos One|September 12, 2015
Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin ExpressionRobert Adams, Barbara Nicke, Hans-Dieter Pohlenz, et al.
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Initiation of high frequency multi-drug resistance following kinase targeting by siRNAsCharles Swanton, Barbara Nicke, Michela Marani, et al.
Molecular Biology of the Cell|April 20, 2004
The transcriptional response to Raf activation is almost completely dependent on Mitogen-activated Protein Kinase Kinase activity and shows a major autocrine componentAlmut Schulze, Barbara Nicke, Patricia H Warne, et al.
Cell Death & Disease|February 9, 2018
PDE5 inhibition eliminates cancer stem cells via induction of PKA signalingSaskia Klutzny, Anna Anurin, Barbara Nicke, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposureAlvin J X Lee, Phillip East, Stuart Pepper, et al.
Cell|June 2, 2007
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in miceSurbhi Gupta, Antoine R Ramjaun, Paula Haiko, et al.
Cancer Research|September 23, 2003
Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastomaAngelo Agathanggelou, Ivan Bièche, Jalal Ahmed-Choudhury, et al.
Cancer Cell|June 15, 2007
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugsCharles Swanton, Michela Marani, Olivier Pardo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|November 4, 2004
RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy?Charles Swanton, Barbara Nicke, Julian Downward
Handbook of Experimental Pharmacology|September 3, 2015
Functional Genomics in Pharmaceutical Drug DiscoveryRobert Adams, Michael Steckel, Barbara Nicke
Plos One|September 12, 2015
Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin ExpressionRobert Adams, Barbara Nicke, Hans-Dieter Pohlenz, et al.
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Initiation of high frequency multi-drug resistance following kinase targeting by siRNAsCharles Swanton, Barbara Nicke, Michela Marani, et al.
Molecular Biology of the Cell|April 20, 2004
The transcriptional response to Raf activation is almost completely dependent on Mitogen-activated Protein Kinase Kinase activity and shows a major autocrine componentAlmut Schulze, Barbara Nicke, Patricia H Warne, et al.
Cell Death & Disease|February 9, 2018
PDE5 inhibition eliminates cancer stem cells via induction of PKA signalingSaskia Klutzny, Anna Anurin, Barbara Nicke, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposureAlvin J X Lee, Phillip East, Stuart Pepper, et al.
Cell|June 2, 2007
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in miceSurbhi Gupta, Antoine R Ramjaun, Paula Haiko, et al.
Cancer Research|September 23, 2003
Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastomaAngelo Agathanggelou, Ivan Bièche, Jalal Ahmed-Choudhury, et al.
Cancer Cell|June 15, 2007
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugsCharles Swanton, Michela Marani, Olivier Pardo, et al.
Pageof 2